The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes.
about
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesisInteraction between the mouse homologue of CD99 and its ligand PILR as a mechanism of T cell receptor-independent thymocyte apoptosis.Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses.T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation.CD99 acts as an oncosuppressor in osteosarcomaGingipains of Porphyromonas gingivalis modulate leukocyte adhesion molecule expression induced in human endothelial cells by ligation of CD99.Engagement of CD99 induces apoptosis through a calcineurin-independent pathway in Ewing's sarcoma cells.Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226.Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.Paired Ig-Like Type 2 Receptor-Derived Agonist Ligands Ameliorate Inflammatory Reactions by Downregulating β1 Integrin Activity.CD99 Is Strongly Expressed in Basal Cells of the Normal Adult Epidermis and Some Subpopulations of Appendages: Comparison with Developing Fetal SkinInteraction of CD99 with its paralog CD99L2 positively regulates CD99L2 trafficking to cell surfacesNuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.CD99 at the crossroads of physiology and pathology.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.
P2860
Q24642797-86B85CD2-02AF-476E-960F-0CAECB19FC2FQ33879825-B97CE5C2-064A-47D4-AAD6-ECBBD3FF6132Q33992087-9D779D5E-B25C-41D4-8956-DFF7DA8EF78FQ34412894-ED7AAB55-D866-411D-8786-0A0DA17B687CQ34483649-7E096B00-71A4-4F2E-B490-B99484FB2BE8Q34491722-52E6E7A8-C0BF-4E7D-973F-5A1BEBDE5D12Q35785944-84142A48-F9EE-47A1-8ADE-59AAE09803CCQ36260718-E1F43D8F-F45D-4D78-BA12-7F7F688BE903Q36362633-54A5AA1A-705A-4B80-86A7-C9FFBDB62890Q37121871-CDDDCB72-C729-4EA6-8319-8E7A74631BECQ37297815-48C90792-7319-4963-A01B-7150A0DE0F1EQ37317147-26883E4D-3D23-4CD2-BEA2-67018B03016EQ37461346-15B3501D-1595-4F0F-A8C3-066663D7F7EDQ38298890-E93F9902-C6A8-480E-9721-AAF4EDFED496Q47203268-596641E5-30D4-4D52-B78A-6E2BB748BE5BQ52658031-AB04201D-06B6-4BCA-8341-7C4C78FC4874
P2860
The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The E2 molecule (CD99) specifi ...... ation of CD4+ CD8+ thymocytes.
@en
type
label
The E2 molecule (CD99) specifi ...... ation of CD4+ CD8+ thymocytes.
@en
prefLabel
The E2 molecule (CD99) specifi ...... ation of CD4+ CD8+ thymocytes.
@en
P2093
P1476
The E2 molecule (CD99) specifi ...... ation of CD4+ CD8+ thymocytes.
@en
P2093
J P Breittmayer
P407
P577
1995-01-01T00:00:00Z